$CYAN
CYANOTECH CORP Stock $cyan

$cyan Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924034529 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$5.845M
YoY Change		-8.28%
Cost Of Revenue		$4.366M
YoY Change		1.89%
Gross Profit		$1.479M
YoY Change		-29.17%
Gross Profit Margin		25.3%
Selling, General & Admin		$2.317M
YoY Change		-8.96%
% of Gross Profit		156.66%
Research & Development		$137.0K
YoY Change		-21.71%
% of Gross Profit		9.26%
Depreciation & Amortization		$373.0K
YoY Change		-7.67%
% of Gross Profit		25.22%
Operating Expenses		$2.454M
YoY Change		-9.78%
Operating Profit		-$975.0K
YoY Change		54.27%
Interest Expense		$175.0K
YoY Change		7.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$1.150M
YoY Change		44.65%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$1.150M
YoY Change		44.29%
Net Earnings / Revenue		-19.67%
Basic Earnings Per Share		-$0.16
Diluted Earnings Per Share		-$0.16
COMMON SHARES
Basic Shares Outstanding	7.156M	6.960M
Diluted Shares Outstanding		7.004M

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$780.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$7.185M
Prepaid Expenses
Receivables		$1.592M
Other Receivables
Total Short-Term Assets		$10.13M
YoY Change		-20.18%
LONG-TERM ASSETS
Property, Plant & Equipment		$9.505M
YoY Change		-11.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$122.0K
YoY Change		38.64%
Total Long-Term Assets		$13.79M
YoY Change		-10.45%
TOTAL ASSETS
Total Short-Term Assets		$10.13M
Total Long-Term Assets		$13.79M
Total Assets		$23.91M
YoY Change		-14.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.132M
YoY Change		53.16%
Accrued Expenses		$619.0K
YoY Change		-30.99%
Deferred Revenue		$272.0K
YoY Change		114.17%
Short-Term Debt		$1.000M
YoY Change		-59.68%
Long-Term Debt Due		$6.019M
YoY Change		4.92%
Total Short-Term Liabilities		$9.575M
YoY Change		10.58%
LONG-TERM LIABILITIES
Long-Term Debt		$1.000M
YoY Change		0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$1.000M
YoY Change		0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities		$9.575M
Total Long-Term Liabilities		$1.000M
Total Liabilities		$14.22M
YoY Change		3.99%
SHAREHOLDERS EQUITY
Retained Earnings		-$25.25M
YoY Change		27.54%
Common Stock		$143.0K
YoY Change		10.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$9.692M
YoY Change
Total Liabilities & Shareholders Equity		$23.91M
YoY Change		-14.85%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$1.150M
YoY Change		44.29%
Depreciation, Depletion And Amortization		$373.0K
YoY Change		-7.67%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000768408
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Registrant Name EntityRegistrantName	Cyanotech Corp
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7142700
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7142700
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6947246
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6947246
	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrimeRateMember
CY2024Q3	cyan	Number Of Shareholder Approved Sharebased Compensation Plans NumberOfShareholderApprovedSharebasedCompensationPlans	2	pure
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrimeRateMember
CY2024Q3	ecd	Trd Arr Adoption Date TrdArrAdoptionDate	March 6, 2024
CY2024Q3	ecd	Trd Arr Ind Name TrdArrIndName	Michael Davis
CY2024Q3	ecd	Trd Arr Ind Title TrdArrIndTitle	Chairman of the Company’s Board of Directors
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-14602
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1206026
	dei	Entity Address Address Line1 EntityAddressAddressLine1	73-4460 Queen Kaahumanu Hwy. #102
	dei	Entity Address City Or Town EntityAddressCityOrTown	Kailua-Kona
	dei	Entity Address State Or Province EntityAddressStateOrProvince	HI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	96740
	dei	City Area Code CityAreaCode	808
	dei	Local Phone Number LocalPhoneNumber	326-1353
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7155858
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	780000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	707000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1592000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2102000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	7185000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	7313000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	568000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	469000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	10125000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	10591000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9505000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10109000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4161000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4284000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	122000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	128000	usd
CY2024Q3	us-gaap	Assets Assets	23913000	usd
CY2024Q1	us-gaap	Assets Assets	25112000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2132000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1439000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	619000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	757000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	272000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	198000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	533000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	530000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1000000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1240000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9575000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8554000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3646000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3744000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	14221000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	13298000	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	143000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	139000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34802000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34576000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25253000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22901000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9692000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11814000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23913000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25112000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5845000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6373000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11743000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11519000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4366000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4285000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8787000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7899000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1479000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2088000	usd
	us-gaap	Gross Profit GrossProfit	2956000	usd
	us-gaap	Gross Profit GrossProfit	3620000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1244000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1160000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2513000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2434000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1073000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1385000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2238000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2661000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	137000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	175000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	221000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	366000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2454000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2720000	usd
	us-gaap	Operating Expenses OperatingExpenses	4972000	usd
	us-gaap	Operating Expenses OperatingExpenses	5461000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-975000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-632000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2016000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1841000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	175000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	163000	usd
	us-gaap	Interest Expense InterestExpense	336000	usd
	us-gaap	Interest Expense InterestExpense	323000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1150000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-795000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2352000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2164000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1150000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-797000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2352000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2166000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7004000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6366000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6976000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6328000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7004000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6366000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6976000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6328000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	10660000	usd
CY2024Q3	cyan	Stock Issued During Period Value Director Stock Grants StockIssuedDuringPeriodValueDirectorStockGrants	94000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	usd
CY2024Q3	cyan	Stock Issued Value Issued In Lieu Of Cash For Prior Year Board Fees StockIssuedValueIssuedInLieuOfCashForPriorYearBoardFees	40000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-4000	usd
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1150000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9692000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15040000	usd
CY2023Q3	cyan	Stock Issued During Period Value Director Stock Grants StockIssuedDuringPeriodValueDirectorStockGrants	126000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-11000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	49000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-797000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	14407000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11814000	usd
	cyan	Stock Issued During Period Value Director Stock Grants StockIssuedDuringPeriodValueDirectorStockGrants	94000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000	usd
	cyan	Stock Issued Value Issued In Lieu Of Cash For Prior Year Board Fees StockIssuedValueIssuedInLieuOfCashForPriorYearBoardFees	40000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-4000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	90000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2352000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9692000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16347000	usd
	cyan	Stock Issued During Period Value Director Stock Grants StockIssuedDuringPeriodValueDirectorStockGrants	126000	usd
	cyan	Stock Issued Value Issued In Lieu Of Cash For Prior Year Board Fees StockIssuedValueIssuedInLieuOfCashForPriorYearBoardFees	15000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-11000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	96000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2166000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	14407000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2352000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2166000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	751000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	811000	usd
	cyan	Amortization Correction Of Debt Issuance Costs AmortizationCorrectionOfDebtIssuanceCosts	13000	usd
	cyan	Amortization Correction Of Debt Issuance Costs AmortizationCorrectionOfDebtIssuanceCosts	15000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	140000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	242000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	194000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	222000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-510000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	110000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-128000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1116000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	100000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	651000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	437000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-98000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-188000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	74000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	38000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-112000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-236000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-201000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	105000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	286000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-286000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	240000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	335000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	275000	usd
	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	750000	usd
	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	500000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	127000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	118000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	379000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	310000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	73000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	262000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	707000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	974000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	780000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1236000	usd
	us-gaap	Interest Paid Net InterestPaidNet	330000	usd
	us-gaap	Interest Paid Net InterestPaidNet	273000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	780000	usd
CY2024Q3	cyan	Working Capital Deficit WorkingCapitalDeficit	550000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	707000	usd
CY2024Q1	cyan	Working Capital Deficit WorkingCapitalDeficit	2037000	usd
CY2024Q3	cyan	Long Term Debt And Capital Lease Obligations Current And Noncurrent LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent	3093000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported. Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentration Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">A significant portion of revenues and accounts receivables are derived from a few major customers. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2024, </em>two customers individually accounted for 33% and 9% of the Company’s total net sales, and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2023, </em>two customers individually accounted for 42% and 16% of the Company’s total net sales. For the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> September 30, 2024, </em><span style="-sec-ix-hidden:c120491485">two</span> customers individually accounted for 32% and 11% of the Company’s total net sales, and for the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> September 30, 2023, </em>two customers individually accounted for 38% and 17% of the Company’s total net sales. Two customers accounted for 70% and 72% of the Company’s accounts receivable balance as of <em style="font: inherit;"> September 30, 2024 </em>and <em style="font: inherit;"> March 31, 2024, </em>respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	33	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	45000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	18000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5845000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6373000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11743000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11519000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:45pt;">Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. There was <em style="font: inherit;">no</em> impact on previously reported financial statements for the periods presented.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	835000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1149000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3942000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2195000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2058000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3658000	usd
CY2024Q3	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	350000	usd
CY2024Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	311000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	7185000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	7313000	usd
CY2024Q3	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	31000	usd
CY2023Q3	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	0	usd
	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	53000	usd
	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	133000	usd
CY2024Q3	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	15000	usd
CY2023Q3	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	136000	usd
	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	83000	usd
	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	325000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37458000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37398000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28250000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27500000	usd
CY2024Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	297000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	211000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9505000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10109000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	373000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	404000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	751000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	811000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1000000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1240000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	74000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	80000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6019000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5630000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	74000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	80000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	4093000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1000000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	5093000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y10M24D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.074	pure
	us-gaap	Operating Lease Cost OperatingLeaseCost	434000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	409000	usd
CY2024Q3	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	6166000	usd
CY2024Q1	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	6149000	usd
CY2024Q3	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	2005000	usd
CY2024Q1	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	1865000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4161000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4284000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	533000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	530000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3646000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3744000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4179000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4274000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	409000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	822000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	831000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	524000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	395000	usd
CY2024Q3	cyan	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2716000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5697000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1518000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4179000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	187000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	234000	usd
CY2024Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	328000	usd
CY2024Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	327000	usd
CY2024Q3	cyan	Accrued Interest And Legal Liabilities Current AccruedInterestAndLegalLiabilitiesCurrent	28000	usd
CY2024Q1	cyan	Accrued Interest And Legal Liabilities Current AccruedInterestAndLegalLiabilitiesCurrent	32000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	76000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	164000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	619000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	757000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2100000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1217730
CY2024Q3	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Shares Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding	625313
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	297000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.47
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.78
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	347000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	247000
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	125000
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.16
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	75000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.28
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	100000
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.56
	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Weighted Average Grant Date Fair Value Options Granted SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageGrantDateFairValueOptionsGranted	8000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003	pure
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1150000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7004000
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-797000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6366000
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Net Income Loss NetIncomeLoss	-2352000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6976000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Net Income Loss NetIncomeLoss	-2166000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6328000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2024Q3	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	315000
CY2024Q3	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	315000

Files In Submission

Name	View Source	Status
0001437749-24-034529-index-headers.html	Edgar Link	pending
0001437749-24-034529-index.html	Edgar Link	pending
0001437749-24-034529.txt	Edgar Link	pending
0001437749-24-034529-xbrl.zip	Edgar Link	pending
cyan-20240930.xsd	Edgar Link	pending
cyan20240930_10q.htm	Edgar Link	pending
cyanologo1.jpg	Edgar Link	pending
ex_741974.htm	Edgar Link	pending
ex_741975.htm	Edgar Link	pending
ex_741976.htm	Edgar Link	pending
ex_741977.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
cyan-20240930_def.xml	Edgar Link	unprocessable
cyan-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cyan20240930_10q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cyan-20240930_cal.xml	Edgar Link	unprocessable
cyan-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYAN
CYANOTECH CORP Stock $cyan

2024 Q4 Form 10-Q Financial Statement

#000143774924034529 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN CYANOTECH CORP Stock $cyan

2024 Q4 Form 10-Q Financial Statement

#000143774924034529 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN
CYANOTECH CORP Stock $cyan